When compared to control CD8 + T cells, RNA-seq analysis of SRSF1-knockout (KO) cells revealed that SRSF1 inactivation increased glycolytic metabolism, which is known to enhance T cell-mediated tumor immunity. The gene discussed is SRSF1; the disease is neoplasm.